PharmaShots | Incisive News in 3 Shots

Subscribe Now

Quanterix

Quanterix’s Simoa P-Tau 217 Blood Test Receives the US FDA’s Breakthrough Device Designation for Alzheimer’s Disease

Quanterix’s Simoa P-Tau 217 Blood Test Receives the US FDA’s Breakthrough Device Designation for Alzheimer’s Disease

March 5, 2024

Quanterix Entered into a Collaboration with Eli Lilly to Develop Plasma-Based Biomarkers for Alzheimer’s Disease

Quanterix Entered into a Collaboration with Eli Lilly to Develop Plasma-Based Biomarkers for Alzheimer’s Disease

March 2, 2022

PharmaShots Weekly Snapshots (Dec 28- 31, 2020)

PharmaShots Weekly Snapshots (Dec 28- 31, 2020)

December 31, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us